Clinical Trial Update: Cirmtuzumab Consolidation for Treatment of Patients With Detectable CLL on Venetoclax [Phase 2]

View source ↗

Summary

This update outlines a Phase 2 trial of Cirmtuzumab as consolidation therapy for patients with detectable chronic lymphocytic leukemia who are receiving venetoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Cirmtuzumab (cirmtuzumab)
• Venetoclax (venetoclax)

Snippet

Sponsor: University of California, San Diego | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING